ALEXION PHARMACEUTICALS, INC. - FORM 10-Q - EX-32.2 - CERTIFICATION BY VIKAS SINHA, V.P. AND CFO PURSUANT TO SECTION 906

Attached files

file	filename
10-Q - FORM 10-Q - ALEXION PHARMACEUTICALS, INC.	d10q.htm
EX-10.1 - WAIVER AND SECOND AMENDMENT TO CREDIT AGREEMENT - ALEXION PHARMACEUTICALS, INC.	dex101.htm
EX-31.2 - CERTIFICATION BY VIKAS SINHA, V.P. AND CFO PURSUANT TO SECTION 302 - ALEXION PHARMACEUTICALS, INC.	dex312.htm
EX-10.2 - THIRD AMENDMENT TO CREDIT AGREEMENT - ALEXION PHARMACEUTICALS, INC.	dex102.htm
EX-31.1 - CERTIFICATION BY LEONARD BELL, CEO PURSUANT TO SECTION 302 - ALEXION PHARMACEUTICALS, INC.	dex311.htm
EX-32.1 - CERTIFICATION BY LEONARD BELL, CEO PURSUANT TO SECTION 906 - ALEXION PHARMACEUTICALS, INC.	dex321.htm

Exhibit 32.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the quarterly report on Form 10-Q of Alexion Pharmaceuticals, Inc. (the “Company”) for the fiscal quarter ended September 30, 2009 as filed with the Securities and Exchange Commission (the “Report”), I, Vikas Sinha, Senior Vice President and Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)

the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: November 5, 2009		/s/ Vikas Sinha
		Vikas Sinha
		Senior Vice President and Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.

Attached files

ALEXION PHARMACEUTICALS, INC. Reports

Also read